Dr. Jean-Pierre Ayoub discusses the evolving field of ADCs in Canada, comments on additional analysis from DESTINY-Breast06 by Dr. Aditya Bardia, and explores the expanding indications for trastuzumab deruxtecan (T-DXd).
4:10
0
